Sector
PharmaceuticalsOpen
₹624Prev. Close
₹620.8Turnover(Lac.)
₹1,413.3Day's High
₹637.5Day's Low
₹614.0552 Week's High
₹882.852 Week's Low
₹442.8Book Value
₹259.03Face Value
₹10Mkt Cap (₹ Cr.)
2,233.25P/E
0EPS
0Divi. Yield
029 Aug 2024
12:00 AM
AGM
Announcement Date: 29 Aug, 2024
7 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 36 | 36 | 36 | 35.93 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 901.42 | 1,467.13 | 1,491.05 | 1,556.86 |
Net Worth | 937.42 | 1,503.13 | 1,527.05 | 1,592.79 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 1,268.34 | 1,616.88 | 1,321.75 | 560.4 |
yoy growth (%) | -21.55 | 22.32 | 135.85 | |
Raw materials | -653.89 | -724.41 | -598.87 | -293.32 |
As % of sales | 51.55 | 44.8 | 45.3 | 52.34 |
Employee costs | -234.2 | -227.63 | -202.24 | -69.51 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | -88.17 | 220.96 | 112.49 | 1.95 |
Depreciation | -112.01 | -108.31 | -93.67 | -36.55 |
Tax paid | 33.1 | 0 | 0 | 0 |
Working capital | 200.65 | 302.71 | 157.99 | |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -21.55 | 22.32 | 135.85 | |
Op profit growth | -79.14 | 50.2 | 317.87 | |
EBIT growth | -104.22 | 60.44 | 601.98 | |
Net profit growth | -126.5 | 96.42 | 5,668.71 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 1,283.76 | 1,288.92 | 1,443.81 | 1,268.34 | 1,616.88 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,283.76 | 1,288.92 | 1,443.81 | 1,268.34 | 1,616.88 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 8.32 | 5.37 | 22.55 | 20.02 | 28.77 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Independent Directo
RAJAGOPALAN RAMAKRISHNAN
Independent Director
Kausalya Santhanam
Non Executive Director
Arun Kumar
Independent Director
Rajendra Kumar Srivastava
Non Executive Director
Rajiv Vijay Nabar
Non Executive Director
Kartheek Chintalapati Raju
Non Executive Director
Manish Gupta
Executive Director & COO
M Mohan
Managing Director & CEO
Sandeep Rao
Company Sec. & Compli. Officer
Pooja Jaya Kumar
201 Devavrata Sector 17 Vashi,
Navi Mumbai,
Maharashtra - 400703
Tel: 91-22-27892924
Website: http://www.solara.co.in
Email: [email protected]
Subramanian Building,
1ST Floor No 1, Club House Road,
Chennai - 600002
Tel: 91-44-28462700
Website: www.cameoindia.com
Email: [email protected]
Summary
Solara Active Pharma Sciences Limited was incorporated on February 23, 2017 to undertake business in manufacturing, production, processing, formulating, sale, import, export, merchandising, distributi...
Read More
Reports by Solara Active Pharma Sciences Ltd
What is the Solara Active Pharma Sciences Ltd share price today?
What is the Market Cap of Solara Active Pharma Sciences Ltd?
What is the PE and PB ratio of Solara Active Pharma Sciences Ltd?
What is the 52 Week High and Low of Solara Active Pharma Sciences Ltd?
What is the CAGR of Solara Active Pharma Sciences Ltd?
What is the shareholding pattern of Solara Active Pharma Sciences Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.